Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,942,660
+$267,553 QoQ
Shares Held
7,720
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#1,983
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Berkeley Capital Partners, LLC holds $14,092,981 across 9 Drug Manufacturers - General names. ABBV ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,370 | $3,141,608 | |
| 2 | MRK |
Merck & Co., Inc.
|
17,441 | $2,241,168 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
7,720 | $1,942,660 | |
| 4 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 | |
| 5 | NVS |
Novartis AG
|
10,041 | $1,573,625 | |
| 6 | PFE |
Pfizer Inc
|
64,286 | $1,548,006 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,331 | $1,459,572 | |
| 8 | NVO |
Novo Nordisk A S
|
6,115 | $293,153 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,942,660 | 7,720 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,675,107 | 7,702 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,787,705 | 7,824 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,852,088 | 7,999 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,496,282 | 8,061 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,680,140 | 8,019 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,395,478 | 7,853 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,575,297 | 7,977 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,235,630 | 7,204 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,315,126 | 7,222 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,149,102 | 7,415 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,125,552 | 7,551 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,009,666 | 7,494 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,189,537 | 7,464 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,161,329 | 7,186 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $990,738 | 7,382 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,126,951 | 7,358 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,188,752 | 7,333 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $866,830 | 6,402 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $710,647 | 6,588 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $753,561 | 6,690 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $718,364 | 6,638 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $680,295 | 6,349 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $555,057 | 6,337 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $598,799 | 6,099 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $449,825 | 5,904 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||